207 related articles for article (PubMed ID: 33637979)
1. Clinical impact of PCSK9 inhibitor on stabilization and regression of lipid-rich coronary plaques: a near-infrared spectroscopy study.
Ota H; Omori H; Kawasaki M; Hirakawa A; Matsuo H
Eur Heart J Cardiovasc Imaging; 2022 Jan; 23(2):217-228. PubMed ID: 33637979
[TBL] [Abstract][Full Text] [Related]
2. Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.
Zanchin C; Koskinas KC; Ueki Y; Losdat S; Häner JD; Bär S; Otsuka T; Inderkum A; Jensen MRJ; Lonborg J; Fahrni G; Ondracek AS; Daemen J; van Geuns RJ; Iglesias JF; Matter CM; Spirk D; Juni P; Mach F; Heg D; Engstrom T; Lang I; Windecker S; Räber L
Am Heart J; 2021 Aug; 238():33-44. PubMed ID: 33951415
[TBL] [Abstract][Full Text] [Related]
3. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
Räber L; Ueki Y; Otsuka T; Losdat S; Häner JD; Lonborg J; Fahrni G; Iglesias JF; van Geuns RJ; Ondracek AS; Radu Juul Jensen MD; Zanchin C; Stortecky S; Spirk D; Siontis GCM; Saleh L; Matter CM; Daemen J; Mach F; Heg D; Windecker S; Engstrøm T; Lang IM; Koskinas KC;
JAMA; 2022 May; 327(18):1771-1781. PubMed ID: 35368058
[TBL] [Abstract][Full Text] [Related]
4. Coronary lipid-rich plaque characteristics in Japanese patients with acute coronary syndrome and stable angina: A near infrared spectroscopy and intravascular ultrasound study.
Takahashi N; Dohi T; Endo H; Takeuchi M; Doi S; Kato Y; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Minamino T
Int J Cardiol Heart Vasc; 2021 Apr; 33():100747. PubMed ID: 33748401
[TBL] [Abstract][Full Text] [Related]
5. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.
Nicholls SJ; Puri R; Anderson T; Ballantyne CM; Cho L; Kastelein JJ; Koenig W; Somaratne R; Kassahun H; Yang J; Wasserman SM; Scott R; Ungi I; Podolec J; Ophuis AO; Cornel JH; Borgman M; Brennan DM; Nissen SE
JAMA; 2016 Dec; 316(22):2373-2384. PubMed ID: 27846344
[TBL] [Abstract][Full Text] [Related]
6. Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV).
Puri R; Nissen SE; Somaratne R; Cho L; Kastelein JJ; Ballantyne CM; Koenig W; Anderson TJ; Yang J; Kassahun H; Wasserman SM; Scott R; Borgman M; Nicholls SJ
Am Heart J; 2016 Jun; 176():83-92. PubMed ID: 27264224
[TBL] [Abstract][Full Text] [Related]
7. In vivo relationship between near-infrared spectroscopy-detected lipid-rich plaques and morphological plaque characteristics by optical coherence tomography and intravascular ultrasound: a multimodality intravascular imaging study.
Zanchin C; Ueki Y; Losdat S; Fahrni G; Daemen J; Ondracek AS; Häner JD; Stortecky S; Otsuka T; Siontis GCM; Rigamonti F; Radu M; Spirk D; Kaiser C; Engstrom T; Lang I; Koskinas KC; Räber L
Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):824-834. PubMed ID: 31990323
[TBL] [Abstract][Full Text] [Related]
8. Stepwise regression of non-culprit lipid-rich plaque observed using serial near-infrared spectroscopy-intravascular ultrasound and optical coherence tomographic measurements after aggressive cholesterol-lowering treatment: a case report.
Takahashi N; Dohi T; Endo H; Okazaki S
Eur Heart J Case Rep; 2021 Mar; 5(3):ytab095. PubMed ID: 34113771
[TBL] [Abstract][Full Text] [Related]
9. Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study.
Waksman R; Di Mario C; Torguson R; Ali ZA; Singh V; Skinner WH; Artis AK; Cate TT; Powers E; Kim C; Regar E; Wong SC; Lewis S; Wykrzykowska J; Dube S; Kazziha S; van der Ent M; Shah P; Craig PE; Zou Q; Kolm P; Brewer HB; Garcia-Garcia HM;
Lancet; 2019 Nov; 394(10209):1629-1637. PubMed ID: 31570255
[TBL] [Abstract][Full Text] [Related]
10. Impact of PCSK9 inhibitors on coronary atheroma phenotype following myocardial infarction: insights from intravascular imaging.
Abrahams T; Fujino M; Nelson AJ; Nicholls SJ
Curr Opin Cardiol; 2023 Nov; 38(6):504-508. PubMed ID: 37751373
[TBL] [Abstract][Full Text] [Related]
11. Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction.
Nicholls SJ; Kataoka Y; Nissen SE; Prati F; Windecker S; Puri R; Hucko T; Aradi D; Herrman JR; Hermanides RS; Wang B; Wang H; Butters J; Di Giovanni G; Jones S; Pompili G; Psaltis PJ
JACC Cardiovasc Imaging; 2022 Jul; 15(7):1308-1321. PubMed ID: 35431172
[TBL] [Abstract][Full Text] [Related]
12. The influence of high-density lipoprotein cholesterol on maximal lipid core burden indexing thin cap fibrous atheroma lesions as assessed by near infrared spectroscopy.
Dobrolińska MM; Gąsior P; Wańha W; Pietraszewski P; Pociask E; Smolka G; Wojakowski W; Roleder T
Cardiol J; 2021; 28(6):887-895. PubMed ID: 31909469
[TBL] [Abstract][Full Text] [Related]
13. Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering Therapy.
Biccirè FG; Häner J; Losdat S; Ueki Y; Shibutani H; Otsuka T; Kakizaki R; Hofbauer TM; van Geuns RJ; Stortecky S; Siontis GCM; Bär S; Lønborg J; Heg D; Kaiser C; Spirk D; Daemen J; Iglesias JF; Windecker S; Engstrøm T; Lang I; Koskinas KC; Räber L
J Am Coll Cardiol; 2023 Oct; 82(18):1737-1747. PubMed ID: 37640248
[TBL] [Abstract][Full Text] [Related]
14. Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.
Nakamura H; Kataoka Y; Nicholls SJ; Puri R; Kitahara S; Murai K; Sawada K; Matama H; Iwai T; Honda S; Fujino M; Takagi K; Yoneda S; Otsuka F; Nishihira K; Asaumi Y; Tsujita K; Noguchi T
Atherosclerosis; 2022 May; 349():183-189. PubMed ID: 35450750
[TBL] [Abstract][Full Text] [Related]
15. Mature proprotein convertase subtilisin/kexin type 9, coronary atheroma burden, and vessel remodeling in heterozygous familial hypercholesterolemia.
Kataoka Y; Harada-Shiba M; Nakao K; Nakashima T; Kawakami S; Fujino M; Kanaya T; Nagai T; Tahara Y; Asaumi Y; Hori M; Ogura M; Goto Y; Noguchi T; Yasuda S
J Clin Lipidol; 2017; 11(2):413-421.e3. PubMed ID: 28502498
[TBL] [Abstract][Full Text] [Related]
16. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia: A One Center Study.
Kolovou V; Katsiki N; Makrygiannis S; Mavrogieni S; Karampetsou N; Manolis A; Melidonis A; Mikhailidis DP; Kolovou GD
J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):51-58. PubMed ID: 32729335
[TBL] [Abstract][Full Text] [Related]
18. Factors underlying regression of coronary atheroma with potent statin therapy.
Puri R; Nissen SE; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; St John J; Wolski K; Uno K; Kataoka Y; Nicholls SJ
Eur Heart J; 2013 Jun; 34(24):1818-25. PubMed ID: 23644179
[TBL] [Abstract][Full Text] [Related]
19. Effect of alirocumab on coronary atheroma volume in Japanese patients with acute coronary syndromes and hypercholesterolemia not adequately controlled with statins: ODYSSEY J-IVUS rationale and design.
Ako J; Hibi K; Kozuma K; Miyauchi K; Morino Y; Shinke T; Tsujita K; Uno K; Kawabata Y; Hiro T
J Cardiol; 2018 Jun; 71(6):583-589. PubMed ID: 29606415
[TBL] [Abstract][Full Text] [Related]
20. The feasibility and limitation of coronary computed tomographic angiography imaging to identify coronary lipid-rich atheroma in vivo: Findings from near-infrared spectroscopy analysis.
Kitahara S; Kataoka Y; Miura H; Nishii T; Nishimura K; Murai K; Iwai T; Nakamura H; Hosoda H; Matama H; Doi T; Nakashima T; Honda S; Fujino M; Nakao K; Yoneda S; Nishihira K; Kanaya T; Otsuka F; Asaumi Y; Tsujita K; Noguchi T; Yasuda S
Atherosclerosis; 2021 Apr; 322():1-7. PubMed ID: 33706078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
